SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-24-002945
Filing Date
2024-02-06
Accepted
2024-02-06 20:15:45
Documents
1
Period of Report
2024-02-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5960
  Complete submission text file 0001209191-24-002945.txt   7548
Mailing Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121
Business Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121 8587318389
aTYR PHARMA INC (Issuer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ATYR PHARMA, INC. 3545 JOHN HOPKINS COURT, SUITE 250 SAN DIEGO CA 92121
Business Address
DENYES NANCY (Reporting) CIK: 0001640869 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37378 | Film No.: 24601813